Publications by authors named "Paul Matthews"

Gene expression quantitative trait loci are widely used to infer relationships between genes and central nervous system (CNS) phenotypes; however, the effect of brain disease on these inferences is unclear. Using 2,348,438 single-nuclei profiles from 391 disease-case and control brains, we report 13,939 genes whose expression correlated with genetic variation, of which 16.7-40.

View Article and Find Full Text PDF
Article Synopsis
  • * A large study involving nearly 10,000 DCM cases and close to a million controls identified 70 significant genetic locations linked to the disease, revealing the importance of heart muscle cells in its development.
  • * The research also indicates that factors like higher body weight and blood pressure may contribute to DCM, and genetic risk scores can help predict the condition across different populations.
View Article and Find Full Text PDF

Several cardiovascular traits and diseases co-occur with Alzheimer's disease. We mapped their shared genetic architecture using multi-trait genome-wide association studies. Subsequent fine-mapping and colocalisation highlighted 16 genetic loci associated with both Alzheimer's and cardiovascular diseases.

View Article and Find Full Text PDF

Aims: This study aimed to compare the outcomes of two different postoperative management approaches following surgical fixation of ankle fractures: traditional cast immobilization versus the Early Motion and Directed Exercise (EMADE) programme.

Methods: A total of 157 patients aged 18 years or older who underwent successful open reduction and internal fixation (ORIF) of Weber B (AO44B) ankle fractures were recruited to this randomized controlled trial. At two weeks post-surgical fixation, participants were randomized to either light-weight cast-immobilization or the EMADE programme, consisting of progressive home exercises and weekly advice and education.

View Article and Find Full Text PDF

Amyloid-β pathology and neurofibrillary tangles lead to glial activation and neurodegeneration in Alzheimer's disease. In this study, we investigated the relationships between the levels of amyloid-β oligomers, amyloid-β plaques, glial activation and markers related to neurodegeneration in the triple mutation mouse line and in a knock-in line homozygous for the common human amyloid precursor protein ( mouse). The relationships between neuropathological features were characterized with immunohistochemistry and imaging mass cytometry.

View Article and Find Full Text PDF
Article Synopsis
  • Cerebral small vessel disease (cSVD) is a major contributor to stroke and dementia, and currently lacks specific treatments, prompting a study using Mendelian randomization to identify protein associations.
  • The research combined cerebrospinal fluid (CSF) and plasma data with genetic studies to identify 49 proteins linked to cSVD, highlighting 16 that appeared in both fluids and showing connections to immune response and extracellular matrix pathways.
  • Notably, many identified proteins were associated with stroke and dementia, with some already having known drug targets, paving the way for potential new biomarkers and therapies for cSVD.
View Article and Find Full Text PDF
Article Synopsis
  • Cerebral small vessel disease (cSVD) is a significant contributor to stroke and dementia, predominantly indicated by white matter hyperintensities (WMH) seen in MRI scans of older adults.
  • Recent research has linked genetic risk factors for WMH to the microstructure of white matter in young adults, which suggests that early changes in the brain's structure may be relevant to cSVD.
  • A study involving genome-wide association testing identified 21 genetic loci related to neurite density and orientation in young adults, showcasing potential early markers for understanding cSVD's progression and underlying mechanisms.
View Article and Find Full Text PDF
Article Synopsis
  • Vascular disease is linked to dementia risk, and the study aims to clarify how specific markers like white matter hyperintensity (WMH), clinical stroke, and blood pressure (BP) contribute to this risk.
  • The research utilized a two-sample mendelian randomization approach and population-based studies, examining genetic influences on WMH, stroke, and BP in relation to Alzheimer's disease (AD) and all-cause dementia.
  • Findings suggest that a higher WMH burden is causally associated with an increased risk of AD, while certain blood pressure traits might offer a protective effect against dementia.
View Article and Find Full Text PDF

Background: Evidence suggests a link between polyphenol intake and reduced incidence of several chronic diseases. This could arise through associations between polyphenol intake and reduced systemic oxidative stress and subsequent inflammation. However, confirming this association is difficult, as few large cohorts allow for comprehensive assessments of both polyphenol intake and markers of systemic inflammation.

View Article and Find Full Text PDF

Aging is associated with cell senescence and is the major risk factor for AD. We characterized premature cell senescence in postmortem brains from non-diseased controls (NDC) and donors with Alzheimer's disease (AD) using imaging mass cytometry (IMC) and single nuclear RNA (snRNA) sequencing (> 200,000 nuclei). We found increases in numbers of glia immunostaining for galactosidase beta (> fourfold) and p16 (up to twofold) with AD relative to NDC.

View Article and Find Full Text PDF
Article Synopsis
  • Brain perfusion and blood-brain barrier integrity are compromised early in Alzheimer's disease, leading to increased vascular issues.
  • Single nucleus RNA sequencing revealed that endothelial cells in Alzheimer's patients show gene expressions linked to AD susceptibility, particularly involving β-amyloid and impairments in vascular signaling.
  • The study suggests that targeting vascular inflammation and enhancing angiogenesis may help reduce vascular dysfunction and potentially slow down the onset or progression of Alzheimer's disease.
View Article and Find Full Text PDF

Lipids play crucial roles in the susceptibility and brain cellular responses to Alzheimer's disease (AD) and are increasingly considered potential soluble biomarkers in cerebrospinal fluid (CSF) and plasma. To delineate the pathological correlations of distinct lipid species, we conducted a comprehensive characterization of both spatially localized and global differences in brain lipid composition in App mice with spatial and bulk mass spectrometry lipidomic profiling, using human amyloid-expressing (h-Aβ) and WT mouse brains controls. We observed age-dependent increases in lysophospholipids, bis(monoacylglycerol) phosphates, and phosphatidylglycerols around Aβ plaques in App mice.

View Article and Find Full Text PDF

Population-based prospective studies, such as UK Biobank, are valuable for generating and testing hypotheses about the potential causes of human disease. We describe how UK Biobank's study design, data access policies, and approaches to statistical analysis can help to minimize error and improve the interpretability of research findings, with implications for other population-based prospective studies being established worldwide.

View Article and Find Full Text PDF
Article Synopsis
  • Transcranial focused ultrasound (FUS) is a minimally invasive technique that can precisely target specific brain regions and significantly affect neuronal activity, offering potential benefits for treating neurological diseases.
  • Recent studies suggest that FUS, especially when combined with microbubbles, may also help modify the blood-brain barrier and influence the immune cells in the brain, particularly microglia, which play a crucial role in brain maintenance and immune defense.
  • This review explores how FUS impacts microglial function and structure, highlighting changes in important markers and behaviors that could lead to therapeutic strategies for enhancing beneficial microglial roles and addressing harmful responses in brain health and disease.
View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease (AD) shows variability in how patients respond to amyloid beta removal therapy, impacting individual treatment benefits.
  • A study utilized random forest models on the EMERGE trial to create an individual-level treatment response (ITR) score, highlighting significant differences in treatment effects among patients.
  • Findings revealed that the top 25% of responders had distinct characteristics, such as lower hippocampal volume and more advanced disease, suggesting that precision medicine approaches could enhance future AD research and treatment strategies.*
View Article and Find Full Text PDF

Purpose: While there are several prognostic classifiers, to date, there are no validated predictive models that inform treatment selection for oropharyngeal squamous cell carcinoma (OPSCC).Our aim was to develop clinical and/or biomarker predictive models for patient outcome and treatment escalation for OPSCC.

Experimental Design: We retrospectively collated clinical data and samples from a consecutive cohort of OPSCC cases treated with curative intent at ten secondary care centers in United Kingdom and Poland between 1999 and 2012.

View Article and Find Full Text PDF

Importance: There is increasing recognition that vascular disease, which can be treated, is a key contributor to dementia risk. However, the contribution of specific markers of vascular disease is unclear and, as a consequence, optimal prevention strategies remain unclear.

Objective: To disentangle the causal relation of several key vascular traits to dementia risk: (i) white matter hyperintensity (WMH) burden, a highly prevalent imaging marker of covert cerebral small vessel disease (cSVD); (ii) clinical stroke; and (iii) blood pressure (BP), the leading risk factor for cSVD and stroke, for which efficient therapies exist.

View Article and Find Full Text PDF
Article Synopsis
  • Microglial activation is crucial in diseases that involve neuroinflammation and neurodegeneration, with PET scans using TSPO to detect inflammation in the brain, although interpreting these results can be tricky.* -
  • The study finds that while TSPO expression increases in activated microglia in mouse models, it doesn't change in human diseases, indicating a difference in how TSPO is regulated across species.* -
  • Genetic differences in TSPO expression linked to the transcription factor AP1 are noted, suggesting that human TSPO-PET signals are more about the presence of inflammatory cells rather than their activation state.*
View Article and Find Full Text PDF

Background: Microglial activation contributes to both inflammatory damage and repair in experimental ischemic stroke. However, because of the logistical challenges, there have been few clinical imaging studies directly describing inflammatory activation and its resolution after stroke. The purpose of our pilot study was to describe the spatio-temporal profile of brain inflammation after stroke using 18kD translocator protein (TSPO) positron emission tomography (PET) with magnetic resonance (MR) co-registration in the subacute and chronic stage after stroke.

View Article and Find Full Text PDF

Background: Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, degenerative disease of the central nervous system that affects approximately 2.8 million people worldwide. Compelling evidence from observational studies and clinical trials indicates a strong association between brain volume loss (BVL) and the accumulation of disability in MS.

View Article and Find Full Text PDF

Mechanistic research suggests synergistic effects of cardiovascular disease (CVD) and dementia pathologies on cognitive decline. Interventions targeting proteins relevant to shared mechanisms underlying CVD and dementia could also be used for the prevention of cognitive impairment. We applied Mendelian randomisation (MR) and colocalization analysis to investigate the causal relationships of 90 CVD-related proteins measured by the Olink CVD I panel with cognitive traits.

View Article and Find Full Text PDF

Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality with both monogenic and polygenic components. We here report results from the largest HCM genome-wide association study (GWAS) and multi-trait analysis (MTAG) including 5,900 HCM cases, 68,359 controls, and 36,083 UK Biobank (UKB) participants with cardiac magnetic resonance (CMR) imaging. We identified a total of 70 loci (50 novel) associated with HCM, and 62 loci (32 novel) associated with relevant left ventricular (LV) structural or functional traits.

View Article and Find Full Text PDF

Across its clinical development program, ocrelizumab demonstrated efficacy in improving clinical outcomes in multiple sclerosis, including annualized relapse rates and confirmed disability progression. However, as with any new treatment, it was unclear how this efficacy would translate into real-world clinical practice. The objective of this study was to systematically collate the published real-world clinical effectiveness data for ocrelizumab in relapsing remitting multiple sclerosis and primary progressive multiple sclerosis.

View Article and Find Full Text PDF